Politician trade (House)

Stryker Corporation (SYK): Rep. Thomas H. Kean Jr. (NJ07) disclosed a partial sale $1K–$15K

Rep. Thomas H. Kean Jr. (NJ07) disclosed a partial sale of Stryker Corporation in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
24 days
Disclosure lag
Traded
Aug 25, 2025
Disclosed
Sep 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 26, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  2. Jul 31, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  3. Aug 6, 2025Insider · 1 personInsiders: 8 sales (~$75.3M)
  4. Aug 20, 2025InsiderOfficer sold ~$702K of SYK shares in the open market
  5. Aug 25, 2025 · this disclosureCongressDisclosed partial sale of SYK — reported range $1,001 - $15,000

What came next

  1. Aug 25, 2025InsiderOfficer sold ~$195K of SYK shares in the open market
  2. Sep 12, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  3. Sep 24, 2025FDARecall: HARMONIC FOCUS Shears + Adaptive Tissue Technology, 9 cm Length REF: HAR9F, Reprocessed Device for Single Use, STERILEEO, RX ONLY
  4. Sep 25, 2025FDAFDA device clearance: RPS Primary TKA Software; RPS Console; RPS Saw One; RPS Cable; RPS Saw Oscillating Tip Cartridge; RPS Console Cart Attachment; Ball Tip Pointer
  5. Sep 30, 2025FDAFDA device clearance: Allomatrix (Allomatrix Injectable Putty; Allomatrix C; Allomatrix DR; Allomatrix Custom)
  6. Oct 17, 2025FDAFDA device clearance: InZone IST Detachment System; IZDS Connecting Cable
  7. Oct 17, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  8. Oct 24, 2025FDAFDA device clearance: Triathlon® Total Knee System - Triathlon® Gold Femoral Components
  9. Oct 29, 2025FDAFDA device clearance: Synchfix EVT
  10. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  11. Oct 31, 2025FDARecall: NICO BrainPath; Product Number/Product Name NN-8024 BrainPath Shephard's Hook - Greenberg; NN-8025 BrainPath Shephard's Hook - Sugita; NN-8026 BrainPath Shepha…
  12. Oct 31, 2025FDARecall: NICO Myriad Handpiece Product Number/Product Name: NN-8000 15x10 MHP; NN-8001 15x 13 MHP; NN-8002 15x 25 MHP - MINOP; NN-8003 13x10 MHP; NN-8004 13x13 MHP; NN-…
  13. Oct 31, 2025FDARecall: Stryker Arise 1000EX mattress, Part Number 2236000000
  14. Oct 31, 2025FDARecall: Stryker MV3 bariatric bed, Part Number 5900000001
  15. Oct 31, 2025FDARecall: NICO Myriad Illumination Pack Product No. NN-1000 11g Illumination Sleeve/Fiber; Product No. NN-1001 13g Illumination Sleeve/Fiber
  16. Nov 5, 2025Insider · 1 personInsiders: 7 sales (~$87.0M)
  17. Nov 6, 2025Insider · 1 personInsiders: 7 sales (~$97.6M)
  18. Nov 12, 2025FDARecall: The Stryker CranialMask Tracker is a single-use device consisting of a flexible printed circuit board (PCB) with 31 infrared (IR) light-emitting diodes (LEDs)…
  19. Nov 14, 2025InsiderOfficer sold ~$714K of SYK shares in the open market
  20. Nov 18, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

Other recent filings by Rep. Thomas H. Kean Jr. (NJ07)

The full history of Rep. Thomas H. Kean Jr. (NJ07) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Stryker Corporation (SYK) stock, and how much?

Rep. Thomas H. Kean Jr. (NJ07) disclosed a partial sale of Stryker Corporation in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Aug 25, 2025. Disclosed: Sep 18, 2025. That is 24 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Stryker Corporation recently?

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.

Does this mean SYK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data